ReviewHereditary cancer in clinical practice2022

Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.

Sarah Sohyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.